IL1B and Alzheimer disease: Similarly, treatment of 5xFAD mice directly with SB reduced levels of TNF-α, IL-6, interleukin-1 beta (IL-1β), and Iba-1 in the cortex and hippocampus, compared to untreated AD mice [105].